GRUSSENDORF, M. et al.
Malignancy rates in thyroid nodules: a long-term cohort study of 17.592 patients.
WOO, T. et al.
The effect of ophthalmic surgery for Graves’ orbitopathy on quality of life: a systematic review and meta-analysis.
DOUGLAS, R.S. et al.
Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment – OPTIC-X study.
FURMANIAK, J. et al.
TSH receptor specific monoclonal autoantibody K1-70TM targeting of the TSH receptor in subjects with Graves’ disease and Graves’ orbitopathy – results from a phase I clinical trial.
ARES, S. et al.
Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months.
CAPDEVILA, J. et al.
A randomized, double-blind noninferiority study to evaluate the efficacy of the cabozantinib tablet at 60 mg per day compared with the cabozantinib capsules at 140 mg per day in patients with progressive, metastatic medullary thyroid cancer.
VAN DIJK, M.M. et al.
Levothyroxine in euthyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebocontrolled, phase 3 trial.
PAPPA, T. et al.
Thyroid nodule shape independently predicts risk of malignancy
JAVAID, U. et al.
Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population
ROBENSHTOK, E. et al.
Adverse histological features of differentiated thyroid cancer are commonly found in autopsy studies: Implications for treatment guidelines
Letzte Aktualisierung: 07.11.2022